Skip to main content
Log in

Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor

  • Original Works
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

To investigate pathogenic mechanisms in experimental autoimmune myasthenia gravis (EAMG) and myasthenia gravis (MG), we studied the acute and chronic effects in rats of injection of rat monoclonal antibodies (MCABs) directed against the acetylcholine receptor (AChR). Animals were severely weak 12 h after a single injection, at which time macrophages were found invading endplate regions of muscle and cholinesterase-stained regions were separted from the underlying muscle fibers. Ultrastructural studies showed findings identical to the acute phase of EAMG: degenerating postsynaptic membranes and invasion and phagocytosis of endplate regions by macrophages. Animals receiving sublethal doses of MCAB recovered clinically by 4–5 days after injection. Recovery was accompanied by a progressive decrease in the number of macrophages associated with endplates and reapposition to the myofibers of the cholinesterasestained regions. Animals injected once, or repeatedly over several months, remained clinically and electromyographically normal after recovery from the initial episode of weakness, but their endplate ultrastructure was highly simplified with blunted or absent synaptic folds and shallow or absent secondary synaptic clefts. These studies demonstrate that anti-AChR MCABs can induce the changes of both acute and chronic EAMG. There is good correlation between the inflammatory changes and the acute clinical disease but poor correlation between morphological and clinical parameters in the chronic syndrome. The latter observation suggests that severe ultrastructural changes, similar to those seen in chronic EAMG and MG, cannot account, at least in rats, for the clinical and electrophysiologic abnormalities of MG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Nils Erik Gilhus, Socrates Tzartos, … Jan J. G. M. Verschuuren

References

  1. Abramsky O, Aharonov A, Webb C, Fuchs S (1975) Cellular immune response to acetylcholine receptor-rich fraction in patients with myasthenia gravis. Clin Exp Immunol 19:11–16

    Google Scholar 

  2. Bevan S, Kuhlberg RW, Heinemann SF (1977) Human myasthenia sera reduce acetylcholine sensitivity of human muscle cells in tissue culture. Nature 267:263–265

    Google Scholar 

  3. Burres AS, Crayton JW, Gomez CM, Richman DP (1981) Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: Clinical and electrophysiological aspects. Ann Neurol 9:563–568

    Google Scholar 

  4. Conti-Tronconi BC, Morgutti M, Sghirlanzoni A, Clementi F (1979) Cellular immune response against acetylcholine receptor in myasthenia gravis: Relevance to clinical course and pathogenesis. Neurology 29:496–501

    Google Scholar 

  5. Drachman D (1978) Myasthenia gravis, part 1: Pathophysiology and immunopathogenesis. N Engl J Med 298:136–141

    Google Scholar 

  6. Drachman D (1978) Myasthenia gravis, part 2: Clinical correlations and treatment. N Engl J Med 298:186–198

    Google Scholar 

  7. Drachman DB, Adams RN, Josifek LF (1982) Functional activities of anti-AChR antibodies and clinical severity of myasthenia gravis. Neurology 32:A221

    Google Scholar 

  8. Drachman D, Adams RN, Josifek LF, Self SG (1982) Functional activities of auto-antibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 307:769–775

    Google Scholar 

  9. Drachman D, Angus C, Adams R, Michelson JD, Hoffmann BM (1978) Myasthenic antibodies crosslink acethylcholine receptors to accelerate degradation. N Engl J Med 298:1116–1122

    Google Scholar 

  10. Dwyer DS, Kearny JF, Bradley RJ, Kemp GE, Oh SJ (1981) Interaction of human antibody and murine monoclonal antibody with muscle acetylcholine receptor. Ann NY Acad Sci 377:143–157

    Google Scholar 

  11. Engel AG, Lambert EH, Howard FM (1977) Immune complexes (IgG and C3) at the motor endplate in myasthenia gravis: Ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 52:267–280

    Google Scholar 

  12. Engle AG, Lindstrom JM Lambert EH, Lennon VA (1977) Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology 27:307–315

    Google Scholar 

  13. Engel AG, Sakakibara H, Sahashi K, Lindstrom JM, Lambert EH, Lennon VA (1979) Passively transferred experimental autoimmune myasthenia gravis. A study of endplate ultrastructure and binding of immune complexes. Neurology 29:179–188

    Google Scholar 

  14. Engel AG, Santa T (1971) Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann NY Acad Sci 183:46–63

    Google Scholar 

  15. Engel AG, Tsujihata MT, Lambert EH, Lindstrom JM, Lennon VA (1976) Experimental autoimmune myasthenia gravis: A sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlation. J Neuropathol Exp Neurol 35:569–587

    Google Scholar 

  16. Fambrough DM, Drachman DB, Satyamurti S (1973) Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 182:293–295

    Google Scholar 

  17. Fumagalli G, Engel AG, Lindstrom J (1982) Ultrastructural aspects of acetylcholine receptor turnover at normal end-plate and in autoimmune myasthenia gravis. J Neuropathol Exp Neurol 41:567–579

    Google Scholar 

  18. Geha RS (1981) Regulation of immune responses by idiotypicantiidiotypic interactions. New Engl J Med 305:25–38

    Google Scholar 

  19. Gomez CM, Richman DP (1982) Acetylcholine receptor monoclonal antibodies specific for the alpha-bungarotoxin binding site induce acute paralysis. Neurology 32:A221

    Google Scholar 

  20. Gomez CM, Richman DP (1983) Anti-acetylcholine receptor antibodies directed against the α-bungarotoxin binding site induce a unique form of experimental myasthenia. Proc Natl Acad Sci USA 80:4089–4093

    Google Scholar 

  21. Gomez CM, Richman DP (in preparation)

  22. Gomez CM, Richman DP, Berman PW, Burres SA Arnason BGW, Fitch FW (1979) Monoclonal antiacetylcholine receptor antibodies: Evidence for multiple pharmacological specificities. Presented at the 63rd Annual Meeting of the Federation of American Societies for Experimental Biology, Dallas, TX

  23. Gomez C, Richman D, Berman P, Burres SA, Arnason BGW, Fitch FW (1979) Monoclonal antibodies against purified nicotinic acetylcholine receptor. Biochem Biophys Res Commun 88:575–582

    Google Scholar 

  24. Gomez C, Richman D, Berman P, Burres SA, Arnason BGW, Fitch FW (1981) Monoclonal antiacetylcholine receptor antibody: Antibody specificity and effect of passive transfer. Ann NY Acad Sci 377:97–109

    Google Scholar 

  25. Gomez C, Richman D, Wollmann R, Berman P, Arnason BG (1980) Passive transfer of experimental autoimmune myasthenia gravis using monoclonal antiacetylcholine receptor antibodies. Neurology [Abstr] 30:388

    Google Scholar 

  26. Gomez CM, Wollmann RL, Richman DP (1982) Monoclonal antibody to acetylcholine receptor produces simplified endplate architecture. Neurology [Abstr] 32:A221

    Google Scholar 

  27. Granato DA, Fulpius BW, Moody JF (1976) Experimental myasthenia in Balb/c mice immunized with rat acetylcholine receptor from rat denervated muscle. Proc Natl Acad Sci USA 73:2872–2876

    Google Scholar 

  28. Green DPL, Miledi R, Vincent A (1975) Neuromuscular transmission after immunization against acetylcholine receptors. Proc R Soc Lond [Biol] 189:57–68

    Google Scholar 

  29. Heilbronn E, Mattsson C (1974) The nicotinic cholinergic receptor protein: Improved purification method, preliminary amino acid composition and observed auto-immune response. J Neurochem 22:315–317

    Google Scholar 

  30. Heinemann S, Merlie J, Lidstrom J (1978) Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera. Nature 274:65–68

    Google Scholar 

  31. Kao I, Drachman D (1977) Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science 196:527–529

    Google Scholar 

  32. Lambert EH, Lindstrom JM, Lennon VA (1976) End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann NY Acad Sci 274:300–318

    Google Scholar 

  33. Lefvert AK, Bergstrom K (1978) Acetylcholine receptor antibody in myasthenia gravis: purification and characterization. Scand J Immunol 8:525–533

    Google Scholar 

  34. Lefvert AK, Bergstrom K, Matell G, Osterman PO, Pirskanen R (1978) Determination of acetylcholine receptor antibody in myasthenia gravis: Clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry 41:394–403

    Google Scholar 

  35. Lennon VA, Lambert EH (1980) Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 285:238–240

    Google Scholar 

  36. Lennon VA, Lambert EH (1981) Monoclonal auto-antibodies to acetylcholine receptor: evidence for a dominant idiotype and requirement of complement for pathogenicity. Ann NY Acad Sci 377:77–95

    Google Scholar 

  37. Lennon VA, Lindstrom JM, Seybold ME (1975) Experimental autoimmune myasthenia: A model in rats and guinea pigs. J Exp Med, 141:1365–1375

    Google Scholar 

  38. Lennon VA, Lindstrom JM, Seybold ME (1976) Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. Ann NY Acad Sci 274:283–299

    Google Scholar 

  39. Lennon VA, Seybold ME, Lindstrom JM, Cochrane C, Ulevitch R (1978) Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med 147:973–983

    Google Scholar 

  40. Lindstrom JM, Einarson BL, Lennon VA, Seybold ME (1976) Pathological mechanisms in experimental autoimmune myasthenia gravis: Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis. J Exp Med 144:726–738

    Google Scholar 

  41. Lindstrom JM, Engel AG, Seybold ME, Lennon VA, Lambert EH (1976) Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies. J Exp Med 144:739–753

    Google Scholar 

  42. Lindstrom JM, Lambert EH (1978) Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome. Neurology 28:130–138

    Google Scholar 

  43. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane D (1976) Antibody to acetylcholine receptor in myasthenia gravis: prevalence clinical correlates, and diagnostic value. Neurology (Minneap) 26:1054–1059

    Google Scholar 

  44. Möller G (1976) Biology of complement and complement receptors. Transplant Rev 32:1–165

    Google Scholar 

  45. Namba T, Nakamura T, Grob D (1967) Staining for nerve fiber and cholinesterase activity in fresh frozen sections. Am J Clin Pathol 47:75–77

    Google Scholar 

  46. Noguchi S, Drachman DB, Adams RN, Hirsch RL (1980) Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis. Ann Neurol 8:32–37

    Google Scholar 

  47. Patrick J, Lindstrom J (1973) Autoimmune response to acetylcholine receptor. Science 180:871–872

    Google Scholar 

  48. Reiness CG, Weinberg CB, Hall ZW (1978) Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle. Nature 274:68–70

    Google Scholar 

  49. Richman DP, Gomez CM, Berman PW, Burres SA, Fitch FW, Arnason BG (1980) Monoclonal antiacetylcholine receptor antibodies can cause experimental myasthenia. Nature 286:738–739

    Google Scholar 

  50. Richman, DP, Patrick J, Arnason BGW (1976) Cellular immunity in myasthenia gravis: Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med 294:694–698

    Google Scholar 

  51. Simpson JA (1960) Myasthenia gravis: a new hypothesis. Scott Med J 5:419–436

    Google Scholar 

  52. Sobashi K, Engel AG, Lindstrom JM, Lambert EH, Lennon VA (1978) Ultrastructural localization of immune complexes (IgG and C3 at the endplate in experimental autoimmune myasthenia gravis. J Neuropathol Exp Neurol 37:212–223

    Google Scholar 

  53. Tarrab-Hazdai R, Aharanov A, Silman I, Fuch S, Abramsky O (1975) Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor. Nature 256:128–130

    Google Scholar 

  54. Toyka, KV, Birnberger KL, Anzel AP, Schlegel C, Besinger U, Struppler A (1978) Myasthenia gravis: Further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model. J Neurol Neurosurg Psychiatry 41:746–753

    Google Scholar 

  55. Tzartos SJ, Lindstrom JM (1980) Monoclonal antibodies used to probe acetylcholine receptor structure: Localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci USA 77:755–759

    Google Scholar 

  56. Yam LT, Li CY, Crosby WH (1971) Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55:283–290

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by grants from the Muscular Dystrophy Association and the National Institutes of Health (NS15462, A19268)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gomez, C.M., Wollmann, R.L. & Richman, D.P. Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor. Acta Neuropathol 63, 131–143 (1984). https://doi.org/10.1007/BF00697195

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00697195

Key words

Navigation